02.06.2025 - 11:39: BIAL SA [
newsroom]
Porto, Portugal (ots/PRNewswire) - BIAL, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that it will give an oral presentation on its potential disease-modifying compound, BIA 28-6156, at ...
To the press release of BIAL SA